Literature DB >> 22212962

Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.

Denise M Harnois.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22212962      PMCID： PMC3498411          DOI： 10.1016/j.mayocp.2011.11.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

1.  Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.

Authors:  D M Harnois; J Steers; J C Andrews; J C Rubin; H C Pitot; L Burgart; R H Wiesner; G J Gores
Journal:  Liver Transpl Surg       Date:  1999-05

2.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

3.  Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Authors:  M Sherman; K Burak; J Maroun; P Metrakos; J J Knox; R P Myers; M Guindi; G Porter; J R Kachura; P Rasuli; S Gill; P Ghali; P Chaudhury; J Siddiqui; D Valenti; A Weiss; R Wong
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

Review 4.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.

Authors:  Jessica A Davila; Louise Henderson; Jennifer R Kramer; Fasiha Kanwal; Peter A Richardson; Zhigang Duan; Hashem B El-Serag
Journal:  Ann Intern Med       Date:  2011-01-18       Impact factor: 25.391

Review 7.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  8 in total

Review 1.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

2.  Cancer Screening in Refugees and Immigrants: A Global Perspective.

Authors:  Patricia F Walker; Ann Settgast; Malini B DeSilva
Journal:  Am J Trop Med Hyg       Date:  2022-05-09       Impact factor: 3.707

3.  TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.

Authors:  Jae Young Jang; Seong-Jun Kim; Eun Kyung Cho; Soung Won Jeong; Eui Ju Park; Woong Cheul Lee; Sae Hwan Lee; Sang Gyune Kim; Young Seok Kim; Hong Soo Kim; Boo Sung Kim; Wenyu Lin; Raymond T Chung
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

4.  Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma.

Authors:  Refaat R Kamel; Khalda Said Amr; Mie Afify; Yasser A Elhosary; Abdelfattah E Hegazy; Hoda H Fahim; Wafaa M Ezzat
Journal:  Open Access Maced J Med Sci       Date:  2016-03-09

Review 5.  Alternative RNA Splicing in the Pathogenesis of Liver Disease.

Authors:  Nicholas J G Webster
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-21       Impact factor: 5.555

6.  Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.

Authors:  Dan Wang; Sipei Zhang; Tao Zhang; Guoyun Wan; Bowei Chen; Qingqing Xiong; Jie Zhang; Wenxue Zhang; Yinsong Wang
Journal:  Int J Nanomedicine       Date:  2017-12-05

7.  Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods.

Authors:  Lingyan Zhang; Ying Guo; Bibo Li; Juan Qu; Chunbao Zang; Fang Li; Ying Wang; Hua Pang; Shaolin Li; Qingjun Liu
Journal:  Eur J Med Res       Date:  2013-10-01       Impact factor: 2.175

8.  Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire.

Authors:  Joseph C Forbi; David S Campo; Michael A Purdy; Zoya E Dimitrova; Pavel Skums; Guo-liang Xia; Lili T Punkova; Lilia M Ganova-Raeva; Gilberto Vaughan; Yousr Ben-Ayed; William M Switzer; Yury E Khudyakov
Journal:  J Med Virol       Date:  2014-02-12       Impact factor: 2.327
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.